Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials

Clinical Trials of interest to cytokine & interferon researchers. Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT ClinicalTrials.gov ID NCT06130579 Sponsor: Peking University People’s Hospital Information provided by Xiao-Jun Huang, Peking University People’s Hospital (Responsible Party) Last Update Posted 2024-03-21 MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials

Clinical Trials of interest to cytokine & interferon researchers Pegylated Interferon Lambda for Treatment of COVID-19 Infection ClinicalTrials.gov ID NCT04534673 Sponsor Soroka University Medical Center Information provided by Ohad Etzion, Soroka University Medical Center (Responsible Party) Last Update Posted 2023-05-06 Proportion of Clinical Improvement & Type 1 Interferon (IFN) Score [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials

Clinical Trials of interest to cytokine & interferon researchers Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma (ATPIC) ClinicalTrials.gov ID NCT05867004 Sponsor Institut Claudius Regaud Information provided by Institut Claudius Regaud (Responsible Party) Last Update Posted 2023 Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for [READ MORE]

Clinical Trials, contributed by Howard A. Young
Clinical Trials

Clinical Trials

Clinical Trials of interest to cytokine & interferon researchers Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? (BIOSTOP) ClinicalTrials.gov ID NCT03011268 Sponsor Helse Møre og Romsdal HF Information provided by Helse Møre og Romsdal HF (Responsible Party) Last Update Posted 2023-03-17 Evaluation of [READ MORE]